Clonal B cells in Waldenström’s macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling
Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), M. Lia Palomba(Memorial Sloan Kettering Cancer Center)
Cited by 35
Related Papers
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
|Blood Advances|2020|264
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
|Journal of Clinical Oncology|2020|150
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia
|Blood|2017|138
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
|Nature Medicine|2024|127